Table 2.
The differences in co-morbidities among COVID-19 PCR positive patients (cases group) and COVID-19 PCR negative (control group) (N = 142).
| Medical Hx | Positive COVID-19 PCR (cases group) N = 77 (%) | Negative COVID-19 PCR (control group) N = 65 (%) | P -Value |
|---|---|---|---|
| Respiratory diseases | 2 (2.6%) | 10 (15.4%) | 0.001* |
| Malignancy | 2 (2.6%) | 6 (9.2 %) | |
| DM | 8 (10.4%) | 3 (4.6%) | |
| HTN | 12 (15.6%) | 3 (4.6%) | |
| Other chronic diseases | 10 (13%) | 18 (27.7%) | |
| >2 chronic diseases | 43 (55.8%) | 25 (38.5%) |
>2 chronic diseases may include one or more of the following: Hypertension (HTN), Diabetes Mellitus (DM), respiratory or malignant illness.
P<0.05 for chi-square were considered statistically significant, N = number of patients.